Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 1, 2006
CELANESE CORPORATION
(Exact Name of Registrant as specified in its charter)
         
DELAWARE   001-32410   98-0420726
         
(State or other jurisdiction
of incorporation)
  (Commission File
Number)
  (IRS Employer
Identification No.)
1601 West LBJ Freeway, Dallas, Texas 75234-6034
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (972) 443-4000
Not Applicable
(Former name or former address, if changed since last report):
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 2.02 Results of Operations and Financial Condition
Item 7.01 Regulation FD Disclosure
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
EX-99.1: PRESS RELEASE


Table of Contents

Item 2.02 Results of Operations and Financial Condition
     On August 1, 2006, Celanese Corporation (the “ Company ”) issued a press release, dated August 1, 2006, reporting the financial results for its second quarter and year-to-date 2006. A copy of the press release is attached to this Current Report on Form 8-K (“ Current Report ”) as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 2.02 disclosure.
Item 7.01 Regulation FD Disclosure
     On August 1, 2006, David N. Weidman, President and Chief Executive Officer of the Company, and John J. Gallagher III, Executive Vice President and Chief Financial Officer of the Company, will make a presentation to investors and analysts via a webcast and teleconference hosted by the Company. A copy of the slide presentation, which will be presented during the webcast and teleconference, will be posted on the Company’s website at www.celanese.com under the Investor/Presentations & Webcast section.
     The information in this Current Report, including the exhibit attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.
Item 9.01 Financial Statements and Exhibits.
     (c) Exhibits
     
Exhibit Number   Description
 
   
99.1
  Press Release dated August 1, 2006

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
             
    CELANESE CORPORATION
 
           
    By:   /s/Steven M. Sterin
         
 
      Name:   Steven M. Sterin
 
      Title:   Vice President and Corporate Controller
 
           
Date: August 1, 2006
           

 


Table of Contents

Exhibit Index
     
Exhibit Number   Description
 
   
99.1
  Press Release dated August 1, 2006

 

 

Exhibit 99.1
(CELANESE LOGO)
     
 
  Celanese Corporation
 
  Investor Relations
Corporate News Release
  1601 West LBJ Freeway
 
  Dallas, Texas 75234-6034
 
   
 
  Mark Oberle
 
  Phone: +1 972 443 4464
 
  Fax: +1 972 332 9373
 
  Mark.Oberle@celanese.com
Celanese Corporation Reports Continued Strong Second Quarter Results
      Second quarter highlights:
    Net sales increase 11% from prior year to $1,674 million
 
    Operating profit up 7% to $163 million
 
    Diluted EPS is $0.60, an increase of 54%
 
    Adjusted EPS is $0.71, up 34%
 
    Operating EBITDA increases 18% to $308 million
                                 
    Three Months Ended   Six Months Ended
    June 30,   June 30,
 
(in $ millions, except per share data)
    2006       2005       2006       2005  
 
Net sales
    1,674       1,506       3,326       2,984  
Operating profit
    163       152       360       308  
Net earnings
    103       67       220       57  
Basic EPS
  $ 0.64     $ 0.41     $ 1.36     $ 0.35  
Diluted EPS
  $ 0.60     $ 0.39     $ 1.28     $ 0.35  
Adjusted EPS*
  $ 0.71     $ 0.53     $ 1.43     $ 1.21  
Operating EBITDA*
    308       262       612       547  
 
*   Non-U.S. GAAP measures. See reconciliation in tables 1 and 6.
Dallas, August 1, 2006: Celanese Corporation (NYSE: CE) today reported sharply improved second quarter results on continued strong demand and improved performance in its downstream businesses and affiliates. Net sales increased 11% to $1,674 million in the second quarter compared to the same period last year, driven by the addition of sales from the Acetex acquisition and increased volumes. Operating profit rose 7% to $163 million while net earnings increased 54% to $103 million compared to the second quarter of last year.
Improved results were driven by strong affiliate performance, fewer special charges and significantly improved business performance, particularly in the Acetate Products segment, all of which offset increased raw material costs in the quarter. Included in the 2006 results were $4 million related to stock option expense not included in the prior year’s quarter. The company also realized benefits from the increased ownership of Celanese AG shares acquired in 2005.

 


 

     Page 2 of 12
Adjusted earnings per share for the quarter were $0.71, a 34% increase from $0.53 in the same period last year. The tax rate used for adjusted earnings per share for 2006 is 28% while 2005’s rate was 24%. Operating EBITDA for the quarter increased 18% to $308 million from $262 million in the same period of 2005. Excluded from these results are $13 million of expenses related to executive severance and legal costs associated with the squeeze-out of minority shareholders of Celanese AG, and $12 million of special charges.
“Celanese had a solid quarter and our improved performance demonstrates the continued successful execution of our business strategies and the strength of our hybrid model. Additionally, we continue to pursue Celanese-specific opportunities in order to deliver on our cost savings commitments,” said David Weidman, president and chief executive officer. “We are focused on creating value for our shareholders and our diversified portfolio of leading global businesses is well-positioned to meet this objective.”
First Half 2006
Net sales for the first six months of 2006 were $3,326 million, an 11% increase from the same period last year, due to the inclusion of sales from the Acetex acquisition and higher pricing on continued strong demand. Operating profit rose 17% to $360 million, compared to $308 million in the first half of 2005. Operating EBITDA for the first half of 2006 increased to $612 million, compared to $547 million in the first half of last year. Adjusted earnings per share for the first half of the year were $1.43, up 18% from the same period last year. Improved results were driven by continued strong business performance, higher earnings from equity investments, higher dividends from cost investments, lower special charges, and lower minority interests and guaranteed payments.
Recent Business Highlights
    Announced that the company made a $100 million equivalent voluntary prepayment of its term loan facilities, which will be reflected in third quarter 2006 results.
 
    Announced the nomination of two independent directors, Martin G. McGuinn and John K. Wulff, to the Celanese board. Upon approval by shareholders, the Celanese board will be comprised of a total of 11 directors, which will include 6 independent directors.
Second Quarter Segment Overview
Chemical Products
Chemical Products delivered strong results, benefiting from its leading global positions and continued strong demand. Downstream businesses in the segment continued to deliver value in the hybrid business model as margins expanded sequentially. Net sales increased from $1,085 million to $1,194 million compared to the same period last year, primarily due to the addition of sales from the Acetex acquisition. Operating profit decreased by $14 million to $141 million driven by the impact of capacity additions to the industry made in late 2005 and early 2006 as expected. Operating EBITDA, however, increased from $191 million to $206 million, primarily due to the timing of dividends from the company’s Ibn Sina cost investment in Saudi Arabia and the inclusion of earnings from the Acetex acquisition.

 


 

     Page 3 of 12
Ticona Technical Polymers
Ticona’s focus on growth and innovation resulted in increased demand for its key products, which drove improved performance in the quarter. Net sales increased from $223 million to $230 million compared to the same period last year, primarily driven by higher volumes. Excluding last year’s $24 million impairment charge related to the company’s exit from the COC business in 2005, operating profit increased by $9 million to $38 million in the quarter, despite continued raw material pressure. Operating EBITDA for Ticona was $67 million, a $12 million increase from the same period last year. The earnings performance was driven primarily by increased demand, cost improvements, and the benefits of the portfolio realignment associated with the divestiture of the COC business.
Acetate Products
Acetate Products’ ongoing revitalization strategy resulted in improved performance, reflecting the business’ increased earnings profile. Net sales increased $4 million to $176 million compared to the same period last year. Price increases more than offset lower tow volume as the company shifted tow production to its recently expanded China ventures. Operating profit increased by $19 million to $29 million, driven by the benefits of its restructuring efforts. Operating EBITDA improved to $55 million, an increase of $34 million from the same period last year. In addition to the restructuring benefits, the earnings increase reflected higher dividends from the company’s China ventures resulting from the completion of the tow capacity expansions.
Performance Products
Performance Products delivered strong results, leveraging growth and new product launches in the global beverage and confectionary industry. Net sales increased to $48 million compared to $47 million in the same period last year as volume growth of 13% offset expected lower pricing. Operating profit increased to $16 million from $15 million based on strong volume and continued cost improvements in the business. Operating EBITDA rose from $18 million to $21 million as the segment continued to deliver sustained profitability.
Equity and Cost Investments
Cash flow from dividends received from equity and cost investments increased to $58 million compared to $17 million in the same period last year, while the earnings impact increased to $57 million from $19 million. The increase, impacting both cash flow and the income statement, was mainly due to increased dividends from the Ibn Sina cost investment in Saudi Arabia and the acetate tow cost investments in China. The change in Ibn Sina dividends is attributed to timing, while dividends from the China ventures increased due to completed tow expansions.

 


 

     Page 4 of 12
Cash Flow
The company generated $144 million in cash from operating activities during the first six months of 2006. This result was lower than the $190 million generated in the same period last year, primarily due to a seasonal increase in working capital. During the second quarter, the company generated $165 million of cash from operating activities versus $148 million in the same period last year, primarily due to increased dividends from cost investments.
Net debt at the end of the second quarter was $3,140 million, an increase of $93 million from the end of 2005, but a decrease of $66 million from the end of the first quarter 2006. The increase in net debt from the end of 2005 is primarily due to a seasonal increase in working capital, cash set aside for certain financial obligations and timing of payments. The decrease from the end of the first quarter is due to strong operating cash flow generation with lower working capital during the quarter. Cash and cash equivalents at the end of the period were $354 million, a decrease of $36 million from year end 2005, and an increase of $42 million from the end of the first quarter of 2006.
The second half of the year is historically the strongest cash generation period for the company. Celanese expects increased cash generation for the remainder of 2006 and made a $100 million equivalent voluntary prepayment of its term loan facility in July.
Outlook
The company expects all of its businesses to continue to perform at seasonally adjusted high levels. While Chemical Products’ second quarter performance was strong, results were impacted by the timing of capacity additions to the industry, made in late 2005 and early 2006, being absorbed into the market. The company, however, views this as a short-term impact as limited new capacity is expected to enter the market over the next several quarters.
The company, therefore, has tightened its expected guidance range for adjusted earnings per share for 2006 to between $2.50 and $2.80 based on 172 million diluted shares outstanding. The guidance range assumes a 28% tax rate. The company continues to expect that its actual cash taxes will be significantly lower during 2006 due to utilization of net operating losses.
“Our outlook for 2006 continues to be positive, driven by significantly improved earnings in our downstream businesses year over year and an overall favorable business environment,” said Weidman. “Basic chemicals should continue to deliver solid results as the industry absorbs the capacity expansions completed in late 2005. We expect that this favorable supply/demand balance in basic products will continue through at least 2008.”
As a global leader in the chemicals industry, Celanese Corporation makes products essential to every day living. Our products, found in consumer and industrial applications, are manufactured in North America, Europe and Asia. Net sales totaled $6.1 billion in 2005, with approximately 60% generated outside of North America. Known for operational excellence and relentless execution of its business strategies, Celanese delivers value to customers around the globe with innovations and best in class technologies. Based in Dallas, Texas, the company employs approximately 9,300 employees worldwide. For more information on Celanese Corporation, please visit the company’s website at www.celanese.com .

 


 

     Page 5 of 12
Forward-Looking Statements
This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Reconciliation of Non-U.S. GAAP Measures to U.S. GAAP
This release reflects three performance measures, operating EBITDA, adjusted earnings per share and net debt as non-U.S. GAAP measures. The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for operating EBITDA is operating profit; for adjusted earnings per share is earnings per common share-diluted; and for net debt is total debt.
Use of Non-U.S. GAAP Financial Information
    Operating EBITDA, a measure used by management to measure performance, is defined as operating profit from continuing operations, plus equity in net earnings from affiliates, other income and depreciation and amortization, and further adjusted for special charges and other adjustments. Our management believes operating EBITDA is useful to investors because it is one of the primary measures our management uses for its planning and budgeting processes and to monitor and evaluate financial and operating results. Operating EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to operating profit as a measure of operating performance or to cash flows from operating activities as a measure of liquidity. Because not all companies use identical calculations, this presentation of operating EBITDA may not be comparable to other similarly titled measures of other companies. Additionally, operating EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not consider certain cash requirements such as interest payments, tax payments and debt service requirements nor does it represent the amount used in our debt covenants.
 
    Adjusted earnings per share is a measure used by management to measure performance. It is defined as net earnings (loss) available to common shareholders plus preferred dividends, adjusted for special charges and other adjustments, and divided by the number of basic common shares, diluted preferred shares, and options valued using the treasury method. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our ongoing operating performance. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.
 
    Net debt is defined as total debt less cash and cash equivalents. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the company’s capital structure. Our management and credit analysts use net debt to evaluate the company’s capital structure and assess credit quality. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.
Results Unaudited
The results presented in this release, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

 


 

     Page 6 of 12
Preliminary Consolidated Statements of Earnings — Unaudited
                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
(in $ millions, except per share data)   2006   2005     2006   2005
       
Net sales
    1,674       1,506         3,326       2,984  
Cost of sales
    (1,326 )     (1,165 )       (2,611 )     (2,271 )
               
Gross profit
    348       341         715       713  
 
                                 
Selling, general and administrative expenses
    (153 )     (135 )       (305 )     (294 )
Research and development expenses
    (18 )     (23 )       (36 )     (46 )
Special charges
    (12 )     (27 )       (12 )     (65 )
Foreign exchange gain (loss), net
    (1 )     (1 )       (1 )     2  
Loss on disposition of assets, net
    (1 )     (3 )       (1 )     (2 )
               
Operating profit
    163       152         360       308  
 
                                 
Equity in net earnings of affiliates
    18       12         39       27  
Interest expense
    (73 )     (68 )       (144 )     (244 )
Interest income
    9       9         17       24  
Other income, net
    29       18         35       21  
               
Earnings from continuing operations before tax and minority interests
    146       123         307       136  
 
                                 
Income tax provision
    (42 )     (43 )       (87 )     (51 )
       
Earnings from continuing operations before minority interests
    104       80         220       85  
 
                                 
Minority interests
    (1 )     (13 )       (1 )     (38 )
               
Earnings from continuing operations
    103       67         219       47  
 
                                 
Earnings from operation of discontinued operations
                  1       10  
               
Net earnings
    103       67         220       57  
       
 
                                 
Cumulative preferred stock dividend declared
    (2 )     (2 )       (5 )     (4 )
               
Net earnings available to common shareholders
    101       65         215       53  
       
 
                                 
Earnings per common share — basic:
                                 
Continuing operations
  $ 0.64     $ 0.41       $ 1.35     $ 0.28  
Discontinued operations
                  0.01       0.07  
               
Net earnings available to common shareholders
  $ 0.64     $ 0.41       $ 1.36     $ 0.35  
       
 
                                 
Earnings per common share — diluted:
                                 
Continuing operations
  $ 0.60     $ 0.39       $ 1.28     $ 0.28  
Discontinued operations
                        0.07  
               
Net earnings available to common shareholders
  $ 0.60     $ 0.39       $ 1.28     $ 0.35  
       
 
                                 
Weighted average shares — basic
    158.6       158.5         158.6       150.2  
Weighted average shares — diluted
    172.1       170.5         172.0       162.3  
       

 


 

     Page 7 of 12
Preliminary Consolidated Balance Sheets — Unaudited
                 
    June 30,     December 31,  
(in $ millions)   2006     2005  
 
ASSETS
               
Current assets:
               
Cash and cash equivalents
    354       390  
Restricted cash
    44        
Receivables:
               
Trade receivables, net
    997       919  
Other receivables
    556       481  
Inventories
    655       661  
Deferred income taxes
    31       37  
Other assets
    73       91  
     
Total current assets
    2,710       2,579  
 
               
Investments
    815       775  
Property, plant and equipment, net
    2,082       2,040  
Deferred income taxes
    125       139  
Other assets
    442       482  
Goodwill
    906       949  
Intangible assets, net
    488       481  
     
Total assets
    7,568       7,445  
     
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current liabilities:
               
Short-term borrowings and current installments of long-term debt — third party and affiliates
    174       155  
Trade payable — third parties and affiliates
    744       811  
Other current liabilities
    701       787  
Deferred income taxes
    24       36  
Income taxes payable
    255       224  
     
Total current liabilities
    1,898       2,013  
 
               
Long-term debt
    3,320       3,282  
Deferred income taxes
    300       285  
Benefit obligations
    1,110       1,126  
Other liabilities
    454       440  
Minority interests
    68       64  
Shareholders’ equity:
               
Preferred stock
           
Common stock
           
Additional paid-in capital
    348       337  
Retained earnings
    226       24  
Accumulated other comprehensive loss, net
    (156 )     (126 )
     
Total shareholders’ equity
    418       235  
     
Total liabilities and shareholders’ equity
    7,568       7,445  
 

 


 

     Page 8 of 12
Table 1
Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA — a Non-U.S. GAAP Measure. *
                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
(in $ millions)   2006   2005     2006   2005
       
Net Sales
                                 
Chemical Products
    1,194       1,085         2,363       2,129  
Technical Polymers Ticona
    230       223         461       462  
Acetate Products
    176       172         343       337  
Performance Products
    48       47         97       94  
Other Activities
    68       8         129       20  
Intersegment eliminations
    (42 )     (29 )       (67 )     (58 )
               
Total
    1,674       1,506         3,326       2,984  
       
 
                                 
Operating Profit (Loss)
                                 
Chemical Products
    141       155         303       332  
Technical Polymers Ticona
    38       5         79       44  
Acetate Products
    29       10         52       20  
Performance Products
    16       15         33       28  
Other Activities
    (61 )     (33 )       (107 )     (116 )
               
Total
    163       152         360       308  
       
 
                                 
Equity Earnings and Other Income/(Expense) **
                                 
Chemical Products
    16       (6 )       25       8  
Technical Polymers Ticona
    15       16         29       28  
Acetate Products
    21       2         21       2  
Performance Products
    1               1        
Other Activities
    (6 )     18         (2 )     10  
               
Total
    47       30         74       48  
       
 
                                 
Special Charges and Other Adjustments ***
                                 
Chemical Products
    8       3         7       4  
Technical Polymers Ticona
    (2 )     20         (4 )     21  
Acetate Products
                        1  
Performance Products
                         
Other Activities
    19       (10 )       32       35  
               
Total
    25       13         35       61  
       
 
                                 
Depreciation and Amortization Expense
                                 
Chemical Products
    41       39         79       73  
Technical Polymers Ticona
    16       14         32       29  
Acetate Products
    5       9         12       18  
Performance Products
    4       3         8       6  
Other Activities
    7       2         12       4  
               
Total
    73       67         143       130  
       
 
                                 
Operating EBITDA
                                 
Chemical Products
    206       191         414       417  
Technical Polymers Ticona
    67       55         136       122  
Acetate Products
    55       21         85       41  
Performance Products
    21       18         42       34  
Other Activities
    (41 )     (23 )       (65 )     (67 )
               
Total
    308       262         612       547  
       
*   Other Activities primarily includes corporate selling, general and administrative expenses and the results from AT Plastics and captive insurance companies.
 
**   Includes equity earnings from affiliates and other income/(expense), which is primarily dividends from cost investments.
 
***   Excludes adjustments to minority interest, net interest, taxes, depreciation and amortization.

 


 

     Page 9 of 12
Table 2
Factors Affecting Second Quarter 2006 Segment Net Sales Compared to Second Quarter 2005
                                         
(in percent)   Volume   Price   Currency   Other*   Total
 
Chemical Products
    1 %     1 %     1 %     7 %     10 %
Technical Polymers Ticona
    7 %     -2 %     0 %     -2 %     3 %
Acetate Products
    -5 %     7 %     0 %     0 %     2 %
Performance Products
    13 %     -11 %     0 %     0 %     2 %
Total Company
    2 %     0 %     0 %     9 %     11 %
 
Factors Affecting Six Months 2006 Segment Net Sales Compared to Six Months 2005
                                         
(in percent)   Volume   Price   Currency   Other*   Total
 
Chemical Products
    0 %     4 %     -1 %     8 %     11 %
Technical Polymers Ticona
    4 %     0 %     -2 %     -2 %     0 %
Acetate Products
    -5 %     7 %     0 %     0 %     2 %
Performance Products
    18 %     -11 %     -4 %     0 %     3 %
Total Company
    0 %     3 %     -1 %     9 %     11 %
 
*   Primarily represents net sales from the Acetex business (Chemical Products), the absence of sales related to the COC divestiture (Ticona), and AT Plastics and captive insurance companies (Total Company).
Table 3
Cash Flow Information
                 
    Six Months Ended  
    June 30,  
(in $ millions)   2006     2005  
 
Net cash provided by operating activities
    144       190  
Net cash (used in) investing activities
    (141 )     (138 )
Net cash (used in) provided by financing activities
    (51 )     168  
Exchange rate effects on cash
    12       (99 )
Cash and cash equivalents at beginning of period
    390       838  
 
Cash and cash equivalents at end of period
    354       959  
 

 


 

     Page 10 of 12
Table 4
Cash Dividends Received
                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
(in $ millions)   2006   2005     2006   2005
       
Dividends from equity investments
    19       10         36       46  
Dividends from cost investments
    39       7         46       21  
       
Total
    58       17         82       67  
       
Table 5
Net Debt — Reconcilation of a Non-U.S. GAAP Measure
                 
    June 30,   December 31,
(in $ millions)   2006   2005
 
Short-term borrowings and current installments of long-term debt — third party and affiliates
    174       155  
Plus: Long-term debt
    3,320       3,282  
     
Total debt
    3,494       3,437  
Less: Cash and cash equivalents
    354       390  
     
Net Debt
    3,140       3,047  
 

 


 

     Page 11 of 12
Table 6
Adjusted Earnings Per Share — Reconciliation of a Non-U.S. GAAP Measure
                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
(in $ millions, except per share data)   2006   2005     2006   2005
       
Earnings from continuing operations before tax and minority interests
    146       123         307       136  
Non-GAAP Adjustments:
                                 
Special charges and other adjustments *
    25       13         35       61  
Refinancing costs
                        102  
               
Adjusted earnings from continuing operations before tax and minority interests
    171       136         342       299  
Income tax provision on adjusted earnings **
    (48 )     (33 )       (96 )     (74 )
Minority interests
    (1 )     (13 )       (1 )     (38 )
Earnings from discontinued operations, net of tax
                  1       10  
Preferred dividends
    (2 )     (2 )       (5 )     (4 )
               
Adjusted net earnings available to common shareholders
    120       88         241       193  
Add back: Preferred dividends
    2       2         5       4  
               
Adjusted net earnings for diluted adjusted EPS
    122       90         246       197  
       
 
                                 
Diluted shares (millions)
                                 
               
Weighted average shares outstanding
    158.6       158.5         158.6       150.2  
Assumed conversion of Preferred Shares
    12.0       12.0         12.0       12.0  
Assumed conversion of stock options
    1.5               1.4       0.1  
               
Total diluted shares
    172.1       170.5         172.0       162.3  
       
Adjusted EPS from continuing operations
    0.71       0.53         1.42       1.15  
       
 
                                 
Earnings per common share from discontinued operations
                  0.01       0.06  
               
Adjusted EPS
    0.71       0.53         1.43       1.21  
       
*   See Table 7 for details
 
**   The U.S. GAAP tax rate for the three and six months ended June 30, 2006 is 29%. The company is using the 28% rate reflective of the original guidance in Q1 2006.

 


 

     Page 12 of 12
Table 7
Reconciliation of Special Charges to Total Special Charges and Other Adjustments
Special Charges:
                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
(in $ millions)   2006   2005     2006   2005
       
Employee termination benefits
    9       6         11       8  
Plant/office closures
    2       1               2  
               
Total restructuring
    11       7         11       10  
Asset impairments
          24               24  
Insurance recoveries associated with plumbing cases
    (2 )     (4 )       (3 )     (4 )
Other
    3               4       35 *
               
Total
    12       27         12       65  
       
Other Adjustments: **
                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
(in $ millions)   2006   2005     2006   2005
       
Executive severance & legal costs related to Squeeze-Out
    13               23        
Favorable impact on non-operating foreign exchange position
          (14 )             (14 )
Advisor monitoring fee
                        10  
               
Total
    13       (14 )       23       (4 )
       
 
                                 
Total special charges and other adjustments
    25       13         35       61  
       
*   Termination of advisor monitoring fee
 
**   These items are included in net earnings (loss) but not included in special charges.